Skip to Content

R 725 (Montelukast sodium 10 mg (base))

Pill imprint R 725 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; copd; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium 10 mg (base) R 725
Montelukast sodium 10 mg (base) R 725 Front
Montelukast sodium 10 mg (base) R 725 Back
Montelukast sodium 10 mg (base) R 725
Montelukast sodium
R 725
10 mg (base)
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Dr.Reddy's Laboratories Limited
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
ferric oxide yellow
ferrosoferric oxide
ferric oxide red
polyethylene glycol 400
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0875 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.